nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—COMT—Enzymatic degradation of Dopamine by monoamine oxidase—MAOA—alcohol dependence	0.0365	0.0921	CbGpPWpGaD
Methyldopa—COMT—Clearance of dopamine—SLC6A3—alcohol dependence	0.0312	0.0789	CbGpPWpGaD
Methyldopa—COMT—Clearance of dopamine—MAOA—alcohol dependence	0.0264	0.0666	CbGpPWpGaD
Methyldopa—Eruption lichenoid—Citalopram—alcohol dependence	0.0263	0.0605	CcSEcCtD
Methyldopa—Lichenoid keratosis—Citalopram—alcohol dependence	0.0201	0.0462	CcSEcCtD
Methyldopa—DDC—nerve—alcohol dependence	0.0192	0.125	CbGeAlD
Methyldopa—COMT—Neurotransmitter Clearance In The Synaptic Cleft—ALDH2—alcohol dependence	0.0183	0.0462	CbGpPWpGaD
Methyldopa—DDC—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.0169	0.0425	CbGpPWpGaD
Methyldopa—DDC—Dopamine metabolism—MAOB—alcohol dependence	0.0164	0.0415	CbGpPWpGaD
Methyldopa—COMT—Dopamine metabolism—MAOB—alcohol dependence	0.0146	0.0368	CbGpPWpGaD
Methyldopa—COMT—Neurotransmitter Clearance In The Synaptic Cleft—SLC6A3—alcohol dependence	0.0143	0.036	CbGpPWpGaD
Methyldopa—Myocarditis—Citalopram—alcohol dependence	0.0135	0.0311	CcSEcCtD
Methyldopa—Tenderness—Disulfiram—alcohol dependence	0.0128	0.0294	CcSEcCtD
Methyldopa—COMT—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—alcohol dependence	0.012	0.0304	CbGpPWpGaD
Methyldopa—Hyperprolactinaemia—Citalopram—alcohol dependence	0.0115	0.0265	CcSEcCtD
Methyldopa—DDC—Dopamine metabolism—MAOA—alcohol dependence	0.00919	0.0232	CbGpPWpGaD
Methyldopa—DDC—brainstem—alcohol dependence	0.00822	0.0537	CbGeAlD
Methyldopa—DDC—Biogenic Amine Synthesis—MAOA—alcohol dependence	0.0082	0.0207	CbGpPWpGaD
Methyldopa—COMT—Dopamine metabolism—MAOA—alcohol dependence	0.00816	0.0206	CbGpPWpGaD
Methyldopa—VIIth nerve paralysis—Citalopram—alcohol dependence	0.00804	0.0185	CcSEcCtD
Methyldopa—DDC—forebrain—alcohol dependence	0.00794	0.0519	CbGeAlD
Methyldopa—Psychotic disorder—Disulfiram—alcohol dependence	0.00792	0.0182	CcSEcCtD
Methyldopa—DDC—Nicotine Activity on Dopaminergic Neurons—DRD4—alcohol dependence	0.00783	0.0197	CbGpPWpGaD
Methyldopa—DDC—Nicotine Activity on Dopaminergic Neurons—DRD2—alcohol dependence	0.00729	0.0184	CbGpPWpGaD
Methyldopa—COMT—Biogenic Amine Synthesis—MAOA—alcohol dependence	0.00728	0.0184	CbGpPWpGaD
Methyldopa—Parkinsonism—Citalopram—alcohol dependence	0.00726	0.0167	CcSEcCtD
Methyldopa—Erectile dysfunction—Disulfiram—alcohol dependence	0.00645	0.0148	CcSEcCtD
Methyldopa—Jaundice—Disulfiram—alcohol dependence	0.00609	0.014	CcSEcCtD
Methyldopa—DDC—Tryptophan metabolism—MAOB—alcohol dependence	0.00598	0.0151	CbGpPWpGaD
Methyldopa—Hepatitis—Disulfiram—alcohol dependence	0.00561	0.0129	CcSEcCtD
Methyldopa—DDC—Dopaminergic Neurogenesis—SLC6A3—alcohol dependence	0.00558	0.0141	CbGpPWpGaD
Methyldopa—COMT—brainstem—alcohol dependence	0.00544	0.0355	CbGeAlD
Methyldopa—Colitis—Acamprosate—alcohol dependence	0.00528	0.0121	CcSEcCtD
Methyldopa—COMT—forebrain—alcohol dependence	0.00525	0.0343	CbGeAlD
Methyldopa—DDC—midbrain—alcohol dependence	0.00524	0.0342	CbGeAlD
Methyldopa—DDC—Tryptophan metabolism—ALDH2—alcohol dependence	0.00509	0.0128	CbGpPWpGaD
Methyldopa—Breast enlargement—Citalopram—alcohol dependence	0.00508	0.0117	CcSEcCtD
Methyldopa—Nightmare—Naltrexone—alcohol dependence	0.00502	0.0116	CcSEcCtD
Methyldopa—Colitis—Naltrexone—alcohol dependence	0.005	0.0115	CcSEcCtD
Methyldopa—COMT—adrenal cortex—alcohol dependence	0.00486	0.0318	CbGeAlD
Methyldopa—DDC—Parkinsons Disease Pathway—SLC6A3—alcohol dependence	0.00462	0.0116	CbGpPWpGaD
Methyldopa—DDC—endocrine gland—alcohol dependence	0.0046	0.0301	CbGeAlD
Methyldopa—Eczema—Acamprosate—alcohol dependence	0.00444	0.0102	CcSEcCtD
Methyldopa—COMT—cardiovascular system—alcohol dependence	0.00444	0.029	CbGeAlD
Methyldopa—DDC—testis—alcohol dependence	0.00439	0.0287	CbGeAlD
Methyldopa—COMT—pancreas—alcohol dependence	0.00431	0.0282	CbGeAlD
Methyldopa—DDC—nervous system—alcohol dependence	0.00431	0.0282	CbGeAlD
Methyldopa—Libido decreased—Acamprosate—alcohol dependence	0.00431	0.0099	CcSEcCtD
Methyldopa—COMT—Biological oxidations—ADH6—alcohol dependence	0.00425	0.0107	CbGpPWpGaD
Methyldopa—COMT—Phase II conjugation—GGT2—alcohol dependence	0.00417	0.0105	CbGpPWpGaD
Methyldopa—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00417	0.00958	CcSEcCtD
Methyldopa—DDC—liver—alcohol dependence	0.00415	0.0271	CbGeAlD
Methyldopa—DDC—central nervous system—alcohol dependence	0.00415	0.0271	CbGeAlD
Methyldopa—Nasal congestion—Naltrexone—alcohol dependence	0.00415	0.00954	CcSEcCtD
Methyldopa—SLC15A1—digestive system—alcohol dependence	0.00414	0.0271	CbGeAlD
Methyldopa—Libido decreased—Naltrexone—alcohol dependence	0.00407	0.00937	CcSEcCtD
Methyldopa—DDC—Tryptophan metabolism—CYP2E1—alcohol dependence	0.00407	0.0103	CbGpPWpGaD
Methyldopa—COMT—gonad—alcohol dependence	0.00403	0.0263	CbGeAlD
Methyldopa—Endocrine disorder—Citalopram—alcohol dependence	0.00398	0.00915	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00396	0.00911	CcSEcCtD
Methyldopa—Psychotic disorder—Acamprosate—alcohol dependence	0.0039	0.00897	CcSEcCtD
Methyldopa—Amenorrhoea—Citalopram—alcohol dependence	0.00375	0.00863	CcSEcCtD
Methyldopa—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00375	0.00862	CcSEcCtD
Methyldopa—Psychotic disorder—Naltrexone—alcohol dependence	0.00369	0.00849	CcSEcCtD
Methyldopa—Liver function test abnormal—Acamprosate—alcohol dependence	0.00369	0.00848	CcSEcCtD
Methyldopa—COMT—digestive system—alcohol dependence	0.00368	0.0241	CbGeAlD
Methyldopa—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00365	0.00839	CcSEcCtD
Methyldopa—Breast disorder—Acamprosate—alcohol dependence	0.00361	0.0083	CcSEcCtD
Methyldopa—Paraesthesia—Disulfiram—alcohol dependence	0.00358	0.00823	CcSEcCtD
Methyldopa—COMT—Biological oxidations—ADH1A—alcohol dependence	0.00352	0.00888	CbGpPWpGaD
Methyldopa—COMT—blood—alcohol dependence	0.00351	0.0229	CbGeAlD
Methyldopa—Abdominal distension—Acamprosate—alcohol dependence	0.00347	0.00799	CcSEcCtD
Methyldopa—COMT—midbrain—alcohol dependence	0.00347	0.0226	CbGeAlD
Methyldopa—SLC15A1—endocrine gland—alcohol dependence	0.00342	0.0224	CbGeAlD
Methyldopa—Eosinophilia—Acamprosate—alcohol dependence	0.00342	0.00786	CcSEcCtD
Methyldopa—Pancreatitis—Acamprosate—alcohol dependence	0.00338	0.00778	CcSEcCtD
Methyldopa—Angina pectoris—Acamprosate—alcohol dependence	0.00336	0.00773	CcSEcCtD
Methyldopa—DDC—brain—alcohol dependence	0.00329	0.0215	CbGeAlD
Methyldopa—Nightmare—Citalopram—alcohol dependence	0.00318	0.00732	CcSEcCtD
Methyldopa—Angina pectoris—Naltrexone—alcohol dependence	0.00318	0.00732	CcSEcCtD
Methyldopa—Erectile dysfunction—Acamprosate—alcohol dependence	0.00318	0.00731	CcSEcCtD
Methyldopa—Colitis—Citalopram—alcohol dependence	0.00317	0.00728	CcSEcCtD
Methyldopa—Weight increased—Acamprosate—alcohol dependence	0.00314	0.00722	CcSEcCtD
Methyldopa—COMT—Transmission across Chemical Synapses—KCNJ6—alcohol dependence	0.00312	0.00787	CbGpPWpGaD
Methyldopa—SLC15A1—liver—alcohol dependence	0.00309	0.0202	CbGeAlD
Methyldopa—COMT—endocrine gland—alcohol dependence	0.00304	0.0199	CbGeAlD
Methyldopa—COMT—Biological oxidations—ADH4—alcohol dependence	0.00299	0.00755	CbGpPWpGaD
Methyldopa—Weight increased—Naltrexone—alcohol dependence	0.00297	0.00684	CcSEcCtD
Methyldopa—Gynaecomastia—Citalopram—alcohol dependence	0.00295	0.00679	CcSEcCtD
Methyldopa—Lightheadedness—Citalopram—alcohol dependence	0.00295	0.00679	CcSEcCtD
Methyldopa—Infestation NOS—Naltrexone—alcohol dependence	0.00291	0.0067	CcSEcCtD
Methyldopa—Infestation—Naltrexone—alcohol dependence	0.00291	0.0067	CcSEcCtD
Methyldopa—COMT—testis—alcohol dependence	0.0029	0.019	CbGeAlD
Methyldopa—Asthenia—Disulfiram—alcohol dependence	0.00286	0.00658	CcSEcCtD
Methyldopa—COMT—nervous system—alcohol dependence	0.00285	0.0186	CbGeAlD
Methyldopa—Hepatitis—Acamprosate—alcohol dependence	0.00276	0.00635	CcSEcCtD
Methyldopa—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00275	0.00633	CcSEcCtD
Methyldopa—COMT—liver—alcohol dependence	0.00274	0.0179	CbGeAlD
Methyldopa—COMT—central nervous system—alcohol dependence	0.00274	0.0179	CbGeAlD
Methyldopa—ADRA2A—Monoamine GPCRs—CHRM2—alcohol dependence	0.0027	0.00681	CbGpPWpGaD
Methyldopa—COMT—cerebellum—alcohol dependence	0.00268	0.0175	CbGeAlD
Methyldopa—ADRA2A—forebrain—alcohol dependence	0.00267	0.0175	CbGeAlD
Methyldopa—Eczema—Citalopram—alcohol dependence	0.00266	0.00613	CcSEcCtD
Methyldopa—Haemolytic anaemia—Citalopram—alcohol dependence	0.00265	0.0061	CcSEcCtD
Methyldopa—Dizziness—Disulfiram—alcohol dependence	0.00263	0.00606	CcSEcCtD
Methyldopa—Nasal congestion—Citalopram—alcohol dependence	0.00263	0.00604	CcSEcCtD
Methyldopa—Hepatitis—Naltrexone—alcohol dependence	0.00261	0.00601	CcSEcCtD
Methyldopa—Libido decreased—Citalopram—alcohol dependence	0.00258	0.00594	CcSEcCtD
Methyldopa—Connective tissue disorder—Naltrexone—alcohol dependence	0.00257	0.00591	CcSEcCtD
Methyldopa—COMT—Biological oxidations—ADH7—alcohol dependence	0.00254	0.00642	CbGpPWpGaD
Methyldopa—Rash—Disulfiram—alcohol dependence	0.00251	0.00578	CcSEcCtD
Methyldopa—Headache—Disulfiram—alcohol dependence	0.0025	0.00574	CcSEcCtD
Methyldopa—Dopamine—MAOB—alcohol dependence	0.00248	0.156	CrCbGaD
Methyldopa—COMT—Biological oxidations—GGT2—alcohol dependence	0.00244	0.00616	CbGpPWpGaD
Methyldopa—Cardiac disorder—Naltrexone—alcohol dependence	0.00243	0.00558	CcSEcCtD
Methyldopa—Mental disorder—Acamprosate—alcohol dependence	0.00242	0.00557	CcSEcCtD
Methyldopa—COMT—Neuronal System—KCNJ6—alcohol dependence	0.00239	0.00603	CbGpPWpGaD
Methyldopa—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00237	0.00546	CcSEcCtD
Methyldopa—Angiopathy—Naltrexone—alcohol dependence	0.00237	0.00545	CcSEcCtD
Methyldopa—Flatulence—Acamprosate—alcohol dependence	0.00237	0.00545	CcSEcCtD
Methyldopa—Mediastinal disorder—Naltrexone—alcohol dependence	0.00236	0.00542	CcSEcCtD
Methyldopa—Psychotic disorder—Citalopram—alcohol dependence	0.00234	0.00538	CcSEcCtD
Methyldopa—Mental disorder—Naltrexone—alcohol dependence	0.00229	0.00527	CcSEcCtD
Methyldopa—ADRA2A—Amine ligand-binding receptors—CHRM2—alcohol dependence	0.00227	0.00573	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—GABRB1—alcohol dependence	0.00226	0.00569	CbGpPWpGaD
Methyldopa—Flatulence—Naltrexone—alcohol dependence	0.00224	0.00516	CcSEcCtD
Methyldopa—COMT—Biological oxidations—ADH1B—alcohol dependence	0.00223	0.00563	CbGpPWpGaD
Methyldopa—Liver function test abnormal—Citalopram—alcohol dependence	0.00221	0.00508	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00221	0.00557	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR1B—alcohol dependence	0.0022	0.00555	CbGpPWpGaD
Methyldopa—ADRA2A—pancreas—alcohol dependence	0.0022	0.0144	CbGeAlD
Methyldopa—Orthostatic hypotension—Citalopram—alcohol dependence	0.00219	0.00503	CcSEcCtD
Methyldopa—COMT—brain—alcohol dependence	0.00218	0.0142	CbGeAlD
Methyldopa—Breast disorder—Citalopram—alcohol dependence	0.00216	0.00498	CcSEcCtD
Methyldopa—Toxic epidermal necrolysis—Citalopram—alcohol dependence	0.00216	0.00496	CcSEcCtD
Methyldopa—Leukopenia—Acamprosate—alcohol dependence	0.00215	0.00495	CcSEcCtD
Methyldopa—Abdominal distension—Citalopram—alcohol dependence	0.00208	0.00479	CcSEcCtD
Methyldopa—ADRA2A—gonad—alcohol dependence	0.00205	0.0134	CbGeAlD
Methyldopa—Eosinophilia—Citalopram—alcohol dependence	0.00205	0.00471	CcSEcCtD
Methyldopa—Myalgia—Acamprosate—alcohol dependence	0.00205	0.00471	CcSEcCtD
Methyldopa—Arthralgia—Acamprosate—alcohol dependence	0.00205	0.00471	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00203	0.00468	CcSEcCtD
Methyldopa—Pancreatitis—Citalopram—alcohol dependence	0.00203	0.00467	CcSEcCtD
Methyldopa—Angina pectoris—Citalopram—alcohol dependence	0.00202	0.00464	CcSEcCtD
Methyldopa—L-DOPA—DRD4—alcohol dependence	0.00201	0.126	CrCbGaD
Methyldopa—COMT—Phase II conjugation—GGT1—alcohol dependence	0.00197	0.00498	CbGpPWpGaD
Methyldopa—Pancytopenia—Citalopram—alcohol dependence	0.00196	0.00452	CcSEcCtD
Methyldopa—Infection—Acamprosate—alcohol dependence	0.00195	0.00448	CcSEcCtD
Methyldopa—Arthralgia—Naltrexone—alcohol dependence	0.00194	0.00446	CcSEcCtD
Methyldopa—Myalgia—Naltrexone—alcohol dependence	0.00194	0.00446	CcSEcCtD
Methyldopa—ADRA2A—Monoamine GPCRs—DRD4—alcohol dependence	0.00192	0.00485	CbGpPWpGaD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00192	0.00442	CcSEcCtD
Methyldopa—Thrombocytopenia—Acamprosate—alcohol dependence	0.00192	0.00442	CcSEcCtD
Methyldopa—COMT—Transmission across Chemical Synapses—GABRA2—alcohol dependence	0.00192	0.00484	CbGpPWpGaD
Methyldopa—Skin disorder—Acamprosate—alcohol dependence	0.00191	0.00438	CcSEcCtD
Methyldopa—Erectile dysfunction—Citalopram—alcohol dependence	0.00191	0.00438	CcSEcCtD
Methyldopa—Weight increased—Citalopram—alcohol dependence	0.00188	0.00433	CcSEcCtD
Methyldopa—Dopamine—DRD4—alcohol dependence	0.00187	0.117	CrCbGaD
Methyldopa—Oedema—Naltrexone—alcohol dependence	0.00186	0.00427	CcSEcCtD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR1B—alcohol dependence	0.00185	0.00467	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—MAOB—alcohol dependence	0.00185	0.00467	CbGpPWpGaD
Methyldopa—Infection—Naltrexone—alcohol dependence	0.00184	0.00424	CcSEcCtD
Methyldopa—Infestation NOS—Citalopram—alcohol dependence	0.00184	0.00424	CcSEcCtD
Methyldopa—Infestation—Citalopram—alcohol dependence	0.00184	0.00424	CcSEcCtD
Methyldopa—Nervous system disorder—Naltrexone—alcohol dependence	0.00182	0.00419	CcSEcCtD
Methyldopa—Skin disorder—Naltrexone—alcohol dependence	0.0018	0.00415	CcSEcCtD
Methyldopa—Jaundice—Citalopram—alcohol dependence	0.0018	0.00414	CcSEcCtD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR7—alcohol dependence	0.00179	0.00452	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—DRD2—alcohol dependence	0.00179	0.00452	CbGpPWpGaD
Methyldopa—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00179	0.00411	CcSEcCtD
Methyldopa—ADRA2A—blood—alcohol dependence	0.00179	0.0117	CbGeAlD
Methyldopa—ADRA2A—midbrain—alcohol dependence	0.00177	0.0115	CbGeAlD
Methyldopa—Paraesthesia—Acamprosate—alcohol dependence	0.00176	0.00405	CcSEcCtD
Methyldopa—Hepatobiliary disease—Citalopram—alcohol dependence	0.00174	0.00401	CcSEcCtD
Methyldopa—Dopamine—MAOA—alcohol dependence	0.00174	0.109	CrCbGaD
Methyldopa—COMT—Neuronal System—GABRB1—alcohol dependence	0.00173	0.00436	CbGpPWpGaD
Methyldopa—Agranulocytosis—Citalopram—alcohol dependence	0.00172	0.00396	CcSEcCtD
Methyldopa—Dopamine—HTR7—alcohol dependence	0.00172	0.107	CrCbGaD
Methyldopa—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00169	0.0039	CcSEcCtD
Methyldopa—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00169	0.00389	CcSEcCtD
Methyldopa—Bradycardia—Citalopram—alcohol dependence	0.00169	0.00388	CcSEcCtD
Methyldopa—Constipation—Acamprosate—alcohol dependence	0.00168	0.00386	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.00167	0.00422	CbGpPWpGaD
Methyldopa—Paraesthesia—Naltrexone—alcohol dependence	0.00167	0.00384	CcSEcCtD
Methyldopa—Hepatitis—Citalopram—alcohol dependence	0.00166	0.00381	CcSEcCtD
Methyldopa—Connective tissue disorder—Citalopram—alcohol dependence	0.00163	0.00374	CcSEcCtD
Methyldopa—ADRA2A—Amine ligand-binding receptors—DRD4—alcohol dependence	0.00162	0.00408	CbGpPWpGaD
Methyldopa—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.0016	0.00369	CcSEcCtD
Methyldopa—Constipation—Naltrexone—alcohol dependence	0.00159	0.00365	CcSEcCtD
Methyldopa—COMT—Biological oxidations—ALDH2—alcohol dependence	0.00157	0.00397	CbGpPWpGaD
Methyldopa—Body temperature increased—Acamprosate—alcohol dependence	0.00155	0.00357	CcSEcCtD
Methyldopa—ADRA2A—endocrine gland—alcohol dependence	0.00155	0.0101	CbGeAlD
Methyldopa—Cardiac disorder—Citalopram—alcohol dependence	0.00154	0.00354	CcSEcCtD
Methyldopa—ADRA2A—Amine ligand-binding receptors—DRD2—alcohol dependence	0.00151	0.0038	CbGpPWpGaD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR7—alcohol dependence	0.00151	0.0038	CbGpPWpGaD
Methyldopa—Angiopathy—Citalopram—alcohol dependence	0.0015	0.00346	CcSEcCtD
Methyldopa—Dopamine—SLC6A3—alcohol dependence	0.0015	0.094	CrCbGaD
Methyldopa—Mediastinal disorder—Citalopram—alcohol dependence	0.00149	0.00343	CcSEcCtD
Methyldopa—ADRA2A—testis—alcohol dependence	0.00148	0.00966	CbGeAlD
Methyldopa—DDC—Circadian rythm related genes—CRH—alcohol dependence	0.00147	0.00371	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—GABRA2—alcohol dependence	0.00147	0.00371	CbGpPWpGaD
Methyldopa—Body temperature increased—Naltrexone—alcohol dependence	0.00147	0.00338	CcSEcCtD
Methyldopa—ADRA2A—nervous system—alcohol dependence	0.00145	0.00948	CbGeAlD
Methyldopa—Mental disorder—Citalopram—alcohol dependence	0.00145	0.00334	CcSEcCtD
Methyldopa—Hypersensitivity—Acamprosate—alcohol dependence	0.00145	0.00333	CcSEcCtD
Methyldopa—Flatulence—Citalopram—alcohol dependence	0.00142	0.00327	CcSEcCtD
Methyldopa—Asthenia—Acamprosate—alcohol dependence	0.00141	0.00324	CcSEcCtD
Methyldopa—DDC—Amino acid and derivative metabolism—GOT2—alcohol dependence	0.0014	0.00354	CbGpPWpGaD
Methyldopa—ADRA2A—central nervous system—alcohol dependence	0.0014	0.00913	CbGeAlD
Methyldopa—COMT—Transmission across Chemical Synapses—ALDH2—alcohol dependence	0.00139	0.00352	CbGpPWpGaD
Methyldopa—Hypersensitivity—Naltrexone—alcohol dependence	0.00137	0.00315	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—SLC6A4—alcohol dependence	0.00137	0.00345	CbGpPWpGaD
Methyldopa—ADRA2A—cerebellum—alcohol dependence	0.00137	0.00892	CbGeAlD
Methyldopa—Diarrhoea—Acamprosate—alcohol dependence	0.00134	0.00309	CcSEcCtD
Methyldopa—Asthenia—Naltrexone—alcohol dependence	0.00133	0.00306	CcSEcCtD
Methyldopa—Dizziness—Acamprosate—alcohol dependence	0.0013	0.00299	CcSEcCtD
Methyldopa—Leukopenia—Citalopram—alcohol dependence	0.00129	0.00297	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—DRD4—alcohol dependence	0.00128	0.00324	CbGpPWpGaD
Methyldopa—Diarrhoea—Naltrexone—alcohol dependence	0.00127	0.00292	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.00126	0.00318	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—CYP2E1—alcohol dependence	0.00126	0.00317	CbGpPWpGaD
Methyldopa—ADRA2A—Monoamine GPCRs—HTR2A—alcohol dependence	0.00126	0.00317	CbGpPWpGaD
Methyldopa—Vomiting—Acamprosate—alcohol dependence	0.00125	0.00287	CcSEcCtD
Methyldopa—COMT—Metapathway biotransformation—CYP2E1—alcohol dependence	0.00124	0.00313	CbGpPWpGaD
Methyldopa—Rash—Acamprosate—alcohol dependence	0.00124	0.00285	CcSEcCtD
Methyldopa—Dermatitis—Acamprosate—alcohol dependence	0.00124	0.00284	CcSEcCtD
Methyldopa—DDC—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.00123	0.00311	CbGpPWpGaD
Methyldopa—Headache—Acamprosate—alcohol dependence	0.00123	0.00283	CcSEcCtD
Methyldopa—Dizziness—Naltrexone—alcohol dependence	0.00123	0.00282	CcSEcCtD
Methyldopa—Myalgia—Citalopram—alcohol dependence	0.00123	0.00282	CcSEcCtD
Methyldopa—Arthralgia—Citalopram—alcohol dependence	0.00123	0.00282	CcSEcCtD
Methyldopa—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00122	0.0028	CcSEcCtD
Methyldopa—DDC—Amino acid and derivative metabolism—GOT1—alcohol dependence	0.00121	0.00305	CbGpPWpGaD
Methyldopa—L-DOPA—DRD2—alcohol dependence	0.0012	0.0752	CrCbGaD
Methyldopa—Norepinephrine—DRD2—alcohol dependence	0.0012	0.0752	CrCbGaD
Methyldopa—DDC—Circadian rythm related genes—DRD2—alcohol dependence	0.0012	0.00302	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—HTR7—alcohol dependence	0.0012	0.00302	CbGpPWpGaD
Methyldopa—Vomiting—Naltrexone—alcohol dependence	0.00118	0.00272	CcSEcCtD
Methyldopa—Oedema—Citalopram—alcohol dependence	0.00118	0.00271	CcSEcCtD
Methyldopa—Rash—Naltrexone—alcohol dependence	0.00117	0.00269	CcSEcCtD
Methyldopa—Dermatitis—Naltrexone—alcohol dependence	0.00117	0.00269	CcSEcCtD
Methyldopa—Infection—Citalopram—alcohol dependence	0.00117	0.00269	CcSEcCtD
Methyldopa—Nausea—Acamprosate—alcohol dependence	0.00117	0.00268	CcSEcCtD
Methyldopa—Headache—Naltrexone—alcohol dependence	0.00116	0.00268	CcSEcCtD
Methyldopa—COMT—Biological oxidations—GGT1—alcohol dependence	0.00115	0.00291	CbGpPWpGaD
Methyldopa—Nervous system disorder—Citalopram—alcohol dependence	0.00115	0.00265	CcSEcCtD
Methyldopa—Thrombocytopenia—Citalopram—alcohol dependence	0.00115	0.00265	CcSEcCtD
Methyldopa—Skin disorder—Citalopram—alcohol dependence	0.00114	0.00263	CcSEcCtD
Methyldopa—Dopamine—SLC6A4—alcohol dependence	0.00112	0.0703	CrCbGaD
Methyldopa—Dopamine—DRD2—alcohol dependence	0.00112	0.0699	CrCbGaD
Methyldopa—ADRA2A—brain—alcohol dependence	0.00111	0.00725	CbGeAlD
Methyldopa—Nausea—Naltrexone—alcohol dependence	0.0011	0.00254	CcSEcCtD
Methyldopa—COMT—Transmission across Chemical Synapses—GRIN2B—alcohol dependence	0.0011	0.00278	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—SLC6A3—alcohol dependence	0.00109	0.00274	CbGpPWpGaD
Methyldopa—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00107	0.00247	CcSEcCtD
Methyldopa—COMT—Neuronal System—ALDH2—alcohol dependence	0.00107	0.00269	CbGpPWpGaD
Methyldopa—Paraesthesia—Citalopram—alcohol dependence	0.00106	0.00243	CcSEcCtD
Methyldopa—ADRA2A—Amine ligand-binding receptors—HTR2A—alcohol dependence	0.00106	0.00266	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—MAOA—alcohol dependence	0.00103	0.00261	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.00103	0.00259	CbGpPWpGaD
Methyldopa—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00102	0.00234	CcSEcCtD
Methyldopa—DDC—Circadian rythm related genes—AVP—alcohol dependence	0.00101	0.00254	CbGpPWpGaD
Methyldopa—Constipation—Citalopram—alcohol dependence	0.00101	0.00231	CcSEcCtD
Methyldopa—ADRA2A—G alpha (i) signalling events—OPRK1—alcohol dependence	0.000997	0.00252	CbGpPWpGaD
Methyldopa—Body temperature increased—Citalopram—alcohol dependence	0.00093	0.00214	CcSEcCtD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.000925	0.00233	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—MAOA—alcohol dependence	0.000917	0.00231	CbGpPWpGaD
Methyldopa—Hypersensitivity—Citalopram—alcohol dependence	0.000867	0.00199	CcSEcCtD
Methyldopa—COMT—Neuronal System—GRIN2B—alcohol dependence	0.000844	0.00213	CbGpPWpGaD
Methyldopa—Asthenia—Citalopram—alcohol dependence	0.000844	0.00194	CcSEcCtD
Methyldopa—COMT—Neuronal System—SLC6A3—alcohol dependence	0.000832	0.0021	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ADH6—alcohol dependence	0.000818	0.00206	CbGpPWpGaD
Methyldopa—Diarrhoea—Citalopram—alcohol dependence	0.000805	0.00185	CcSEcCtD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.000793	0.002	CbGpPWpGaD
Methyldopa—Dizziness—Citalopram—alcohol dependence	0.000778	0.00179	CcSEcCtD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000755	0.00191	CbGpPWpGaD
Methyldopa—Vomiting—Citalopram—alcohol dependence	0.000748	0.00172	CcSEcCtD
Methyldopa—Rash—Citalopram—alcohol dependence	0.000742	0.00171	CcSEcCtD
Methyldopa—Dermatitis—Citalopram—alcohol dependence	0.000741	0.0017	CcSEcCtD
Methyldopa—Headache—Citalopram—alcohol dependence	0.000737	0.0017	CcSEcCtD
Methyldopa—COMT—Metabolism—ADH6—alcohol dependence	0.000726	0.00183	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—SLC6A3—alcohol dependence	0.000715	0.00181	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—MAOA—alcohol dependence	0.000702	0.00177	CbGpPWpGaD
Methyldopa—Nausea—Citalopram—alcohol dependence	0.000699	0.00161	CcSEcCtD
Methyldopa—DDC—Metabolism—ADH1A—alcohol dependence	0.000678	0.00171	CbGpPWpGaD
Methyldopa—COMT—Biological oxidations—POMC—alcohol dependence	0.000673	0.0017	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—OPRD1—alcohol dependence	0.00067	0.00169	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—PDYN—alcohol dependence	0.000642	0.00162	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000642	0.00162	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.000622	0.00157	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OPRK1—alcohol dependence	0.000604	0.00152	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADH1A—alcohol dependence	0.000602	0.00152	CbGpPWpGaD
Methyldopa—SLC15A1—SLC-mediated transmembrane transport—AVP—alcohol dependence	0.000592	0.00149	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ADH4—alcohol dependence	0.000576	0.00145	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CHRM2—alcohol dependence	0.000561	0.00142	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000544	0.00137	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000533	0.00134	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.000521	0.00131	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—OPRM1—alcohol dependence	0.000515	0.0013	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADH4—alcohol dependence	0.000512	0.00129	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000511	0.00129	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ADH7—alcohol dependence	0.00049	0.00124	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.000478	0.00121	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—NPY—alcohol dependence	0.000474	0.0012	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GGT2—alcohol dependence	0.00047	0.00119	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—HTR1B—alcohol dependence	0.000458	0.00115	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000446	0.00113	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—EP300—alcohol dependence	0.000444	0.00112	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADH7—alcohol dependence	0.000435	0.0011	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ADH1B—alcohol dependence	0.00043	0.00108	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000425	0.00107	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GGT2—alcohol dependence	0.000417	0.00105	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00041	0.00103	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OPRD1—alcohol dependence	0.000406	0.00102	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—DRD4—alcohol dependence	0.0004	0.00101	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—PDYN—alcohol dependence	0.000389	0.000981	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—CNR1—alcohol dependence	0.000382	0.000964	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADH1B—alcohol dependence	0.000382	0.000963	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000377	0.000952	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—DRD2—alcohol dependence	0.000373	0.00094	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000371	0.000937	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000364	0.000918	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000364	0.000917	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CRHR1—alcohol dependence	0.000362	0.000912	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOB—alcohol dependence	0.000356	0.000899	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000354	0.000895	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000346	0.000873	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000346	0.000873	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OPRK1—alcohol dependence	0.000341	0.000861	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CHRM2—alcohol dependence	0.00034	0.000858	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000318	0.000803	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOB—alcohol dependence	0.000316	0.000798	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OPRM1—alcohol dependence	0.000312	0.000788	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OPRK1—alcohol dependence	0.00031	0.000782	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000304	0.000766	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ALDH2—alcohol dependence	0.000303	0.000764	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000301	0.000759	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000296	0.000748	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000296	0.000748	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADH6—alcohol dependence	0.000289	0.000729	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPY—alcohol dependence	0.000287	0.000725	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CRH—alcohol dependence	0.000277	0.000699	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR1B—alcohol dependence	0.000277	0.000699	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ALDH2—alcohol dependence	0.000269	0.000678	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GOT2—alcohol dependence	0.000257	0.00065	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000249	0.000629	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000242	0.000611	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD4—alcohol dependence	0.000242	0.000611	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2E1—alcohol dependence	0.000242	0.000611	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADH1A—alcohol dependence	0.000239	0.000604	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CNR1—alcohol dependence	0.000231	0.000584	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OPRD1—alcohol dependence	0.000229	0.000578	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GOT2—alcohol dependence	0.000229	0.000577	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR7—alcohol dependence	0.000226	0.000569	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD2—alcohol dependence	0.000226	0.000569	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GOT1—alcohol dependence	0.000222	0.000561	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GGT1—alcohol dependence	0.000222	0.000561	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDYN—alcohol dependence	0.00022	0.000555	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2E1—alcohol dependence	0.000215	0.000542	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—alcohol dependence	0.000208	0.000526	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OPRD1—alcohol dependence	0.000208	0.000525	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000208	0.000524	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CRHR1—alcohol dependence	0.000204	0.000516	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADH4—alcohol dependence	0.000203	0.000513	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDYN—alcohol dependence	0.0002	0.000504	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOA—alcohol dependence	0.000199	0.000503	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GGT1—alcohol dependence	0.000197	0.000498	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GOT1—alcohol dependence	0.000197	0.000498	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CHRM2—alcohol dependence	0.000192	0.000485	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AVP—alcohol dependence	0.00019	0.000479	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CRHR1—alcohol dependence	0.000186	0.000468	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OPRK1—alcohol dependence	0.000183	0.000462	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOA—alcohol dependence	0.000177	0.000446	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OPRM1—alcohol dependence	0.000176	0.000445	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CHRM2—alcohol dependence	0.000174	0.00044	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADH7—alcohol dependence	0.000173	0.000436	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GGT2—alcohol dependence	0.000166	0.000418	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000166	0.000418	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPY—alcohol dependence	0.000162	0.00041	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OPRM1—alcohol dependence	0.00016	0.000404	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2A—alcohol dependence	0.000158	0.000399	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CRH—alcohol dependence	0.000157	0.000395	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1B—alcohol dependence	0.000157	0.000395	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADH1B—alcohol dependence	0.000152	0.000383	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPY—alcohol dependence	0.000147	0.000372	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1B—alcohol dependence	0.000142	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CRH—alcohol dependence	0.000142	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD4—alcohol dependence	0.000137	0.000345	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CNR1—alcohol dependence	0.000131	0.00033	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—alcohol dependence	0.00013	0.000327	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR7—alcohol dependence	0.000128	0.000322	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD2—alcohol dependence	0.000128	0.000322	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—alcohol dependence	0.000126	0.000318	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOB—alcohol dependence	0.000126	0.000317	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD4—alcohol dependence	0.000124	0.000314	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OPRD1—alcohol dependence	0.000123	0.00031	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CNR1—alcohol dependence	0.000119	0.0003	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDYN—alcohol dependence	0.000118	0.000298	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR7—alcohol dependence	0.000116	0.000292	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD2—alcohol dependence	0.000116	0.000292	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—alcohol dependence	0.000115	0.000291	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—WASF2—alcohol dependence	0.00011	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CRHR1—alcohol dependence	0.00011	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AVP—alcohol dependence	0.000107	0.000271	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ALDH2—alcohol dependence	0.000107	0.00027	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—WASF1—alcohol dependence	0.000105	0.000265	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CHRM2—alcohol dependence	0.000103	0.00026	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AVP—alcohol dependence	9.75e-05	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OPRM1—alcohol dependence	9.46e-05	0.000239	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GOT2—alcohol dependence	9.09e-05	0.000229	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2A—alcohol dependence	8.93e-05	0.000225	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPY—alcohol dependence	8.71e-05	0.00022	CbGpPWpGaD
Methyldopa—DDC—Metabolism—EP300—alcohol dependence	8.6e-05	0.000217	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2E1—alcohol dependence	8.54e-05	0.000216	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1B—alcohol dependence	8.4e-05	0.000212	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CRH—alcohol dependence	8.4e-05	0.000212	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2A—alcohol dependence	8.11e-05	0.000205	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GOT1—alcohol dependence	7.84e-05	0.000198	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GGT1—alcohol dependence	7.84e-05	0.000198	CbGpPWpGaD
Methyldopa—COMT—Metabolism—EP300—alcohol dependence	7.64e-05	0.000193	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—EP300—alcohol dependence	7.49e-05	0.000189	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD4—alcohol dependence	7.34e-05	0.000185	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—alcohol dependence	7.13e-05	0.00018	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOA—alcohol dependence	7.03e-05	0.000177	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CNR1—alcohol dependence	7.01e-05	0.000177	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR7—alcohol dependence	6.84e-05	0.000173	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD2—alcohol dependence	6.84e-05	0.000173	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—alcohol dependence	6.48e-05	0.000163	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AVP—alcohol dependence	5.76e-05	0.000145	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2A—alcohol dependence	4.79e-05	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—alcohol dependence	4.58e-05	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—alcohol dependence	3.83e-05	9.66e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—EP300—alcohol dependence	3.04e-05	7.66e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EP300—alcohol dependence	2.54e-05	6.41e-05	CbGpPWpGaD
